Br J Clin Pharmacol. 2016 May 16. doi: 10.1111/bcp.13008. [Epub ahead of print]
Recommendations for Genetic Testing to Reduce the Incidence of Anthracycline-induced Cardiotoxicity.
Aminkeng F1,2, Ross CJ2,3, Rassekh SR2,4, Hwang S5, Rieder MJ6, Bhavsar AP2,3, Smith A2,7, Sanatani S2, Gelmon KA8, Bernstein D9, Hayden MR1,2,10,Amstutz U2,3,11, Carleton BC2,7; CPNDS Clinical Practice Recommendations Group.
This article is protected by copyright. All rights reserved.
Anthracycline; anthracycline-induced cardiotoxicity; cancer; chemotherapy; clinical practice recommendations; congestive heart failure; pharmacogenomic testing
- [PubMed - as supplied by publisher]